(RTTNews) - BioCryst Pharmaceuticals, Inc. (BCRX) Monday announced new data from an analysis of U.S. claims data of patients with hereditary angioedema (HAE).

ALBANY – Phoebe Putney Memorial Hospital recently re-opened its completely renovated and updated angiography suite, which includes new technology that paves the way for more advanced procedures and ...

Luke Combs, Eric Church, Billy Strings, and James Taylor will play the "Concert for Carolina" on October 26th, with proceeds ...

Despite challenges, AngioDynamics Inc (ANGO) shows progress towards profitability and strategic market expansion in its first ...

AngioDynamics (NASDAQ:ANGO) lost ~14% of value on Thursday, recording its second biggest intraday loss for the year as the ...

AngioDynamics (ANGO) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.12 per share a year ago. These figures are ...

Background The aim of this study is to assess the feasibility of identifying the hemodynamic status of intracranial atherosclerotic stenosis (ICAS) using angio-based fractional flow (FF) calculated ...

The indicated CIN has been verified by Bed-and-Breakfast.it on the National Database of Accommodation Facilities, confirming its match with the establishment. This ensures compliance with official ...